GSE239844 crizotinib 7 v 12 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE239844_crizotinib_7_v_12_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE239844_crizotinib_7_v_12_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE239844_crizotinib_7_v_12_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE239844_crizotinib_7_v_12_human_up.

Results found

Linked to

 

Label

Description

 

Gene

WASP family homolog 2, pseudogene

Gene

SORBS2 antisense RNA 1

Gene

solute carrier family 25 member 5 pseudogene 1

Gene

nuclear speckle splicing regulatory protein 1 pseudogene 1

Gene

antisense of IGF2R non-protein coding RNA

Gene

MT-ND3 pseudogene 22

Gene

MT-ND4 pseudogene 9

Gene

uncharacterized LOC105377672

Gene

PLBD1 antisense RNA 2

Gene

RN7SK pseudogene 160

  • Gene

    WASP family homolog 2, pseudogene


  • Gene

    SORBS2 antisense RNA 1


  • Gene

    solute carrier family 25 member 5 pseudogene 1


  • Gene

    nuclear speckle splicing regulatory protein 1 pseudogene 1


  • Gene

    antisense of IGF2R non-protein coding RNA


  • Gene

    MT-ND3 pseudogene 22


  • Gene

    MT-ND4 pseudogene 9


  • Gene

    uncharacterized LOC105377672


  • Gene

    PLBD1 antisense RNA 2


  • Gene

    RN7SK pseudogene 160

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.